Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 907-728-6 | CAS number: -
Acute oral toxicity: > 5000 mg/kg bw, based on read-across from Beta-pinene, which was tested in OECD TG 401.
Acute oral toxicity was performed with Beta-pinene similar to the guideline OECD TG 401. Ten male rats were used and they were administered the substance at the dose of 5000 mg/kg bw. One rat of ten died during the study on day 7. No symptoms in rats were observed. The acute oral LD50 for the substance in rats was determined to be greater than 5000 mg/kg bw.
The acute oral toxicity of Rosemarel was assessed using read across from Beta-pinene (CAS# 127-91-3). First the study with the analogue is described and thereafter the read across justification is presented.
Acute oral toxicity study with Beta-pinene:
Acute oral toxicity was performed with Beta-pinene similar to the guideline OECD TG 401, pre-GLP. Ten male rats were used and they were administered the substance at the dose of 5000 mg/kg bw. One rat of ten died during the study on day 7. No symptoms in rats were observed. The acute oral LD50 for the substance in rats was determined to be greater than 5000 mg/kg bw.
The acute oral toxicity of Rosemarel using read across from Beta-pinene (CAS#127-91-3)
Introduction and hypothesis for the analogue approach
Rosemarel is a multi-constituent. The major part is the constituent Beta-pinene (51%) and this constituent has a hexyl ring bridged with one carbon, to which two methyl groups are attached. At the alpha position there is a double bonded methyl group attached to the hexyl ring, which is the functional group. The minor constituent (36%) has the same backbone. The functional group is an epoxide in the place where there is the double bonded methyl group in the other component. For Rosemarel data on acute oral toxicity are lacking.
In accordance with Article 13 of REACH, lacking information should be generated whenever possible by means other than vertebrate animal tests, i. e. applying alternative methods such as in vitro tests, QSARs, grouping and read-across. For assessing the acute oral toxicity of Rosemarel the analogue approach is selected because for one closely related analogue acute oral toxicity information is available which can be used for read across.
Hypothesis: Rosemarel has similar acute oral toxicity compared to the Beta-pinene, resulting in a similar LD50. Although Beta-pinene as such presents a different reactivity than the epoxide constituent of Rosemarel, once systemically available, Beta-pinene will be partly oxidized to epoxide, so the target and source substances will be very similar and are predicted to have similar systemic toxicity.
Available information: The source chemical Beta-pinene has been tested in a an acute oral toxicity test with 10 rats (Moreno, 1975; similar to OECD TG 401, non-GLP) with one dose of 5000 mg/kg bw and the test result receives a reliability of 2.
Target chemical and source chemical(s)
The target is Rosemarel, and the source is Beta-pinene. Chemical structures of the target chemical and the source chemical are shown in the data matrix below. Also physico-chemical properties thought to be relevant for acute oral toxicity are listed in there.
Purity / Impurities
Rosemarel consists of Beta-pinene (51 %) and its oxidised form- the epoxide (36 %). The impurities are all below < 10%.
Analogue approach justification
According to Annex XI 1.5, read across can be used to replace testing when the similarity can be based on a common backbone and a common functional group. When using read across, the result derived should be applicable for C&L and/or risk assessment and it should be presented with adequate and reliable documentation.
Beta-pinene was selected as an analogue because it is Rosemarel’s major constituent, and when it is oxidised, Beta-pinene becomes Rosemarel’s minor constituent.
Structural similarities and differences:
Rosemarel contains 51% Beta-pinene and thus the overlap between the analogues is already 51%. The epoxide constituent has the same backbone as Beta-pinene but the double bond is oxidized into the epoxide component of Rosemarel.
Absorption: Rosemarel’s constituents (Beta-pinene and Rosemarel’s epoxide) have similar absorption potential based on the fact of being liquids, on their low molecular weight (ca. 150) and on their physico-chemical properties that favour oral absorption (e.g. log Kow around 3.2 - 4.4).
Metabolisation: Beta-pinene will oxidize into the epoxide during the metabolisation and thereafter both constituents of Rosemarel will follow a similar pathway.
Fig. The sequence of Phase 1 metabolic steps for Rosemarel’s Beta-pinene (1ststructure), Rosemarel’s epoxide (2ndstructure) and the hydrolysed product (3rdstructure), which are possibly conjugated during Phase 2 metabolic pathways.
Uncertainty of the prediction:
There is no remaining uncertainty. First of all, Rosemarel contains 51% of Beta-pinene and secondly, Beta-pinene will oxidize to the epoxide during metabolization. This means that also for the epoxide constituent the LD50 > 5000 mg/kg bw can be anticipated.
Conclusions per endpoint for C&L and dose descriptor
When using read across the result derived should be applicable for C&L and/or risk assessment and be presented with adequate and reliable documentation.For Beta-pinene a well conducted acute oral toxicity test is available (Reliability2) with an LD50 > 5000 mg/kg bw. Based on these data for Beta-pinene, also for Rosemarel an LD50 > 5000 mg/kg bw can be derived.
Final conclusion on hazard and C&L: Rosemarel has an LD50 > 5000 mg/kg bw.
Data matrix: Information to support the read across for Rosemarel from Beta-pinene to assess the acute oral toxicity of Rosemarel.
Name of substance
Rosemarel and its two constituents: Beta-pinene and its oxidation product
C10H16 and C10H16O
127-91-3 and 6931-54-0, respectively
To be registered for 2018
136.24 and 152.24
Colourless to slight yellow liquid (IFF, 2016)
<-20 (IFF, 2016)
-20 (ECHA site)
Boiling point (oC)
172.2 (IFF, 2016)
166-179 (ECHA site)
Vapour pressure (Pa at 25oC)
345.9 (IFF, 2016)
851 (ECHA site)
Water solubility (mg/l)
7.1 and 338 (C)
45.7 (IFF, 2016)
6.95 (ECHA site)
4.35 and 2.95 (C)
3.2-3.4 (IFF, 2016)
4.4 (ECHA site)
Acute oral toxicity (mg/kg bw)
Read across from Beta-pinene
LD50 > 5000
C: calculated value, the physico-chemical data were generated with EPISuite (version 4.1).
The substance does not need to be classified for acute toxicity by the oral route, based on the EU CLP regulation (1272/2008) and its amendments.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again